fashion -WSS

fashion

author：knowledge 2025-09-03 05:38:18 - browse：8

SAN DIEGO — One of the toughest subtypes of acute leukemia involves a genetic alteration in the KMT2A gene. Many cancers with this genetic alteration end up relapsing or don’t respond to treatment, but new data presented at the annual American Society of Hematology meeting offer hope of a new targeted therapy for these patients.

The study, called the Phase 2 Augment-101 trial, tested Syndax’s revumenib in patients with relapsed or refractory leukemia with these KMT2A genetic rearrangements. Overall, about 63% of the patients responded to the treatment, with many able to receive a potentially curative stem cell transplant later on, which is often the ultimate goal for patients with relapsed or refractory patients, said Ibrahim Aldoss, a hematologist-oncologist at City of Hope and the study’s presenter, in an interview.

“KMT2A-rearranged diseases represent 10% of all leukemia. They can be exceptionally hard to treat,” Aldoss said. “The median overall survival remains low with current available treatment. Right now there’s no targeted therapy for KMT2A-rearranged disease. We’re really excited about revumenib as it targets the mutation, and we’re seeing encouraging outcomes.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

WSS

Medicare solvency divides Republicans at the presidential debate

Air quality improving but still lags in Black, Hispanic communities

Diversify hospital leadership teams to protect BIPOC patient health

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Amylyx ALS drug failure raises questions and concerns

FDA approves Recor Medical high blood pressure device

focus

fashion

explore

At least 13 dead in Texas as scorching temps continue

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Virginia high school admissions case could be legal follow

Extreme heat events are a public health emergency

DIEP, the 'gold standard' of breast reconstruction, is under threat

Just how do doctors, lawmakers, and the public define abortion?

Dobbs anniversary: the lost opportunity of abortion as health care

HPV cancer vaccine study demonstrates efficacy

The high cost of giving birth even with insurance

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

hotspot

The drug industry has found itself all alone in Washington

FDA approves potent Eli Lilly obesity drug, Zepbound

The drug industry has found itself all alone in Washington

Change Healthcare payments predicted restored March 15

FDA approves Recor Medical high blood pressure device

The new shift in health care is toward less care

explore

hotspot

explore

entertainment